acceptodds
Under review as a conference paper at ICLR 2027

ObserveTrace: Explicit Evidence States for Partially Observed EHR Decisions

Abstract

At the moment a renal-risk medication is ordered, no local creatinine can mean never measured, advertised by an external exchange but unavailable, or too old for dosing; a note-derived value can be present yet uncertain. Standard code–value timelines collapse these conditions even though they imply different evidence needs and safety actions. ObserveTrace makes the observation process a first-class model interface: activated evidence requirements become canonical, round-trip-parseable events with value, units, time, provenance, and one of five evidence states. The same event object drives a 7B decoder, constrained alerts, frozen safety rules, and reviewer cards. Observability-aware denoising (OAD) reconstructs workflow-conditioned evidence losses, while incremental clinical consistency (ICC) regularizes adjacent-prefix decisions only when a frozen clinical protocol detects no rule or threshold change. Across 847K high-risk orders from 312K patients at seven health systems, ObserveTrace-7B records 3.2 (2.8–3.7) queue-reaching misses per 1,000 eligible orders, versus 3.8 (3.3–4.4) for an information-, backbone-, and training-budget-matched structured long-context model (paired difference -0.6 (-1.0 to -0.2), ); its false-alert point estimate is also lower, 42.3 versus 43.7. In a fully crossed study, replacing a plain timeline with the complete interface transformation lowers misses from 9.1 to 5.1 before either objective. On 128,640 held-out gate-stable prefix pairs, ICC lowers argmax changes from 0.218 (0.206–0.231) to 0.129 (0.121–0.138), while the action-update rate on 34,920 gate-changing pairs is 0.924 (0.912–0.935). Endpoint concordance is 95.6% with blinded re-adjudication agreement ; a later 184.4K-order silent study preserves 2.9–3.4 logged queue-reaching misses per 1,000 across Epic, Cerner, and MEDITECH workflows. These results establish explicit evidence state as an effective common boundary for partially observed longitudinal decisions.

Then back it, or bet against it.

Related papers

Open the market on this paper to see 7 more related papers.